Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ: 001540)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,130.00
-20.00 (-0.28%)
Oct 11, 2024, 9:00 AM KST

Ahn-Gook Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
80,694106,948104,448122,613148,969123,186
Upgrade
Market Cap Growth
-11.04%2.39%-14.82%-17.69%20.93%8.10%
Upgrade
Enterprise Value
129,266100,25581,42996,41096,61771,837
Upgrade
Last Close Price
7100.009410.008966.3510201.3512144.019870.23
Upgrade
PE Ratio
5.2682.9014.8429.66-105.7944.61
Upgrade
PS Ratio
0.320.460.510.751.040.79
Upgrade
PB Ratio
0.480.710.680.801.030.83
Upgrade
P/FCF Ratio
-1.00-15.72-91.41-47.84-11.526.72
Upgrade
P/OCF Ratio
-8.23-80.5458.4083.2913.315.58
Upgrade
EV/Sales Ratio
0.510.430.400.590.670.46
Upgrade
EV/EBITDA Ratio
9.989.945.6928.1620.8511.45
Upgrade
EV/EBIT Ratio
17.6119.818.68-88.93-1967.5729.71
Upgrade
EV/FCF Ratio
-1.54-14.74-71.26-37.62-7.473.92
Upgrade
Debt / Equity Ratio
0.470.120.130.130.140.20
Upgrade
Debt / EBITDA Ratio
7.061.751.405.904.494.62
Upgrade
Debt / FCF Ratio
-0.93-2.60-17.51-7.88-1.611.58
Upgrade
Asset Turnover
0.951.010.930.780.680.72
Upgrade
Inventory Turnover
2.762.993.132.692.532.76
Upgrade
Quick Ratio
1.211.251.531.751.892.22
Upgrade
Current Ratio
1.761.731.982.232.492.70
Upgrade
Return on Equity (ROE)
9.33%0.65%4.47%2.52%-0.95%1.45%
Upgrade
Return on Assets (ROA)
1.27%1.37%2.64%-0.32%-0.01%0.70%
Upgrade
Return on Capital (ROIC)
1.61%1.84%3.37%-0.40%-0.02%0.88%
Upgrade
Earnings Yield
19.02%1.21%6.58%3.21%-0.88%2.06%
Upgrade
FCF Yield
-103.89%-6.36%-1.09%-2.09%-8.68%14.89%
Upgrade
Dividend Yield
3.09%2.34%----
Upgrade
Payout Ratio
16.29%193.81%36.52%64.00%-99.42%
Upgrade
Buyback Yield / Dilution
-0.00%0.12%0.65%9.44%-10.37%2.56%
Upgrade
Total Shareholder Return
3.08%2.46%0.65%9.44%-10.37%2.56%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.